WASHINGTON, Nov. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Colgate-Palmolive/Tom's of Maine Inc.: * * * To: Mr. Noel Wallace, Chief Executive Officer, Colgate-Palmolive/Tom's of Maine, Inc., 300 Park Avenue, New York, NY 10022, United States, Noel_Wallace@colpal.com Dear Mr. Wallace: The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Tom's of Maine, Inc., FEI 1218077, at 27   more